Vectura believes in life science clusters


Perhaps GoCo Health Innovation City can be seen as Hagastaden's equivalent in Mölndal. Today, the new district for health innovation is emerging next to AstraZeneca. The Japanese world-leading company Fujirebio Diagnostics and the listed Swedish pioneer in transplant technology XVIVO Perfusion are among the companies moving here. Joel Ambré, CEO of Vectura Fastigheter reflects on the need for meeting places for health innovation.

Illustration GoCo Health Innovation City

Read the full blog post (in Swedish) >>